Recommended positive controls: 293T, A431, HeLa, HepG2, A549, H1299, HCT116, MCF-7.
Predicted reactivity: Mouse (92%), Rat (91%), Pig (92%), Rabbit (96%), Bovine (94%).
Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The Vasoactive Intestinal Polypeptide Receptor 2 (VPAC2) is a member of a family of three G-protein coupled receptors which mediate VIP (vasoactive intestinal peptide) and PACAP (pituitary adenlyate cyclase activating peptide) function in a variety of tissues. Together, the VPAC1 and VPAC2 receptors compose a subtype of the VIP receptor. Expression of the VIP and PACAP receptors has been linked to the presence of human tumors.
⚠WARNING: This product can expose you to chemicals including mercury, which is known to the State of California to cause birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: BAR; Bile acid receptor; farnesoid X nuclear receptor; Farnesoid X-activated receptor; Farnesol receptor HRR-1; FXR; HRR-1; HRR1; Nuclear receptor subfamily 1 group H member 4; Retinoid X receptor-interacting protein 14; RIP14; RXR-interacting protein 14
Gene Aliases: BAR; FXR; HRR-1; HRR1; NR1H4; RIP14
UniProt ID: (Human) Q96RI1
Entrez Gene ID: (Human) 9971